TGFB1 and prostate cancer: It is possible the coupled interference of TGF-β1 and BMP-2 by anti-WISP1 treatment could in turn alter the composition of the extracellular matrix (ECM), now known to be affected by and influential to prostate cancer cell behavior [47].